MCHUGH THOMAS S
Insider CIK 1240547 · AVDL Chief Financial Officer · KVA Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer deriv | 2026-02-12 | 2026-02-12 | 175,000 | — | $0 | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer deriv | 2026-02-12 | 2026-02-12 | 150,000 | — | $0 | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer deriv | 2026-02-12 | 2026-02-12 | 72,000 | — | $0 | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer deriv | 2026-02-12 | 2026-02-12 | 250,000 | — | $0 | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer deriv | 2026-02-12 | 2026-02-12 | 157,500 | — | $0 | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer deriv | 2026-02-12 | 2026-02-12 | 200,000 | — | $0 | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | D To issuer | 2026-02-12 | 2026-02-12 | 100,400 | $21.00 | $2.11M | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award deriv | 2025-03-05 | 2025-03-07 | 72,000 | — | $0 | 72,000 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award | 2025-03-05 | 2025-03-07 | 12,600 | — | $0 | 100,400 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | P Buy | 2024-12-13 | 2024-12-16 | 2,300 | $10.44 | $24.0K | 87,800 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | P Buy | 2024-12-11 | 2024-12-12 | 5,000 | $10.49 | $52.5K | 85,500 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award deriv | 2024-02-20 | 2024-03-04 | 157,500 | — | $0 | 157,500 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | P Buy | 2024-01-16 | 2024-01-16 | 2,000 | $14.50 | $29.0K | 80,500 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | P Buy | 2023-08-14 | 2023-08-14 | 2,000 | $14.45 | $28.9K | 78,500 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award deriv | 2023-06-05 | 2023-06-05 | 175,000 | — | $0 | 175,000 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | P Buy | 2022-11-29 | 2022-11-30 | 5,000 | $7.80 | $39.0K | 76,500 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | P Buy | 2022-05-27 | 2022-05-31 | 50,000 | $2.14 | $107.0K | 71,500 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award deriv | 2021-12-07 | 2021-12-09 | 150,000 | — | $0 | 150,000 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award deriv | 2020-12-08 | 2020-12-09 | 200,000 | — | $0 | 200,000 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | P Buy | 2020-09-18 | 2020-09-21 | 4,000 | $6.00 | $24.0K | 21,500 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | P Buy | 2020-08-28 | 2020-09-01 | 7,500 | $6.77 | $50.8K | 17,500 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | P Buy | 2020-08-13 | 2020-08-17 | 10,000 | $7.78 | $77.8K | 10,000 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | A Award deriv | 2019-12-02 | 2019-12-03 | 250,000 | $3.45 | $862.5K | 250,000 | SEC↗ |
| KVA/KVB K-V Pharmaceutical Co | A Award deriv | 2013-09-27 | 2013-10-04 | 40,327 | — | $0 | 40,327 | SEC↗ |
| KVA/KVB K-V Pharmaceutical Co | A Award deriv | 2013-09-16 | 2013-10-04 | 86,806 | — | $0 | 86,806 | SEC↗ |
| KVA/KVB KV PHARMACEUTICAL CO /DE/ | J Other deriv | 2013-09-16 | 2013-09-18 | 35,000 | — | $0 | 0 | SEC↗ |
| KVA/KVB KV PHARMACEUTICAL CO /DE/ | J Other deriv | 2013-09-16 | 2013-09-18 | 20,000 | — | $0 | 0 | SEC↗ |
| KVA/KVB KV PHARMACEUTICAL CO /DE/ | J Other deriv | 2013-09-16 | 2013-09-18 | 25,000 | — | $0 | 0 | SEC↗ |
| KVA/KVB KV PHARMACEUTICAL CO /DE/ | J Other deriv | 2013-09-16 | 2013-09-18 | 35,000 | — | $0 | 0 | SEC↗ |
| KVA/KVB KV PHARMACEUTICAL CO /DE/ | J Other deriv | 2013-09-16 | 2013-09-18 | 20,000 | — | $0 | 0 | SEC↗ |
| KVA/KVB KV PHARMACEUTICAL CO /DE/ | J Other deriv | 2013-09-16 | 2013-09-18 | 5,000 | — | $0 | 0 | SEC↗ |
| KVA KV PHARMACEUTICAL CO /DE/ | A Award deriv | 2012-03-28 | 2012-03-30 | 35,000 | — | $0 | 35,000 | SEC↗ |